Identification of Determinants of Ligand Binding Affinity and Selectivity in the Prostaglandin D2 Receptor CRTH2

Autor: Terry P. Lybrand, Richard M. Breyer, Aaron N. Hata
Rok vydání: 2005
Předmět:
Models
Molecular

Phenylalanine
Indomethacin
Receptors
Prostaglandin

Glutamic Acid
Enzyme-Linked Immunosorbent Assay
Ligands
Binding
Competitive

Models
Biological

Biochemistry
Cell Line
Receptors
G-Protein-Coupled

Mice
chemistry.chemical_compound
Cell Movement
Cyclic AMP
Hypersensitivity
Functional selectivity
Enzyme-linked receptor
Animals
Humans
Receptors
Immunologic

Receptor
Molecular Biology
Prostaglandin D2 receptor
Inflammation
Alanine
Chemotactic Factors
Dose-Response Relationship
Drug

Chemotaxis
Ligand binding assay
Anti-Inflammatory Agents
Non-Steroidal

Cell Biology
Flow Cytometry
Ligand (biochemistry)
Receptor–ligand kinetics
Protein Structure
Tertiary

Kinetics
chemistry
Mutation
Mutagenesis
Site-Directed

Prostaglandins
Eicosanoids
Tyrosine
lipids (amino acids
peptides
and proteins)

Prostaglandin D2
Protein Binding
Zdroj: Journal of Biological Chemistry. 280:32442-32451
ISSN: 0021-9258
Popis: The chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) is a G protein-coupled receptor that mediates the pro-inflammatory effects of prostaglandin D(2) (PGD(2)) generated in allergic inflammation. The CRTH2 receptor shares greatest sequence similarity with chemoattractant receptors compared with prostanoid receptors. To investigate the structural determinants of CRTH2 ligand binding, we performed site-directed mutagenesis of putative mCRTH2 ligand-binding residues, and we evaluated mutant receptor ligand binding and functional properties. Substitution of alanine at each of three residues in the transmembrane (TM) helical domains (His-106, TM III; Lys-209, TM V; and Glu-268, TM VI) and one in extracellular loop II (Arg-178) decreased PGD(2) binding affinity, suggesting that these residues play a role in binding PGD(2). In contrast, the H106A and E268A mutants bound indomethacin, a nonsteroidal anti-inflammatory drug, with an affinity similar to the wild-type receptor. HEK293 cells expressing the H106A, K209A, and E268A mutants displayed reduced inhibition of intracellular cAMP and chemotaxis in response to PGD(2), whereas the H106A and E268A mutants had functional responses to indomethacin similar to the wild-type receptor. Binding of PGE(2) by the E268A mutant was enhanced compared with the wild-type receptor, suggesting that Glu-268 plays a role in determining prostanoid ligand selectivity. Replacement of Tyr-261 with phenylalanine did not affect PGD(2) binding but decreased the binding affinity for indomethacin. These results provided the first details of the ligand binding pocket of an eicosanoid-binding chemoattractant receptor.
Databáze: OpenAIRE